BMS 150 mg 3624 (Reyataz 150 mg)
Generic Name: atazanavir
Pill imprint BMS 150 mg 3624 has been identified as Reyataz 150 mg.
Reyataz is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for BMS 150 mg 3624 (Reyataz 150 mg)
Reyataz
- Generic Name:
- atazanavir
- Imprint:
-
BMS 150 mg
3624 - Strength:
- 150 mg
- Color:
- Blue
- Size:
- 19.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Protease inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00003-3624
- Inactive Ingredients:
- crospovidone
lactose monohydrate
magnesium stearate
gelatin
FD&C Blue No. 2
titanium dioxide
ferric oxide red
ferric oxide yellow
isopropyl alcohol
ammonia
propylene glycol
butyl alcohol
alcohol
ferrosoferric oxide
shellac
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68258-9142 | Dispensing Solutions Inc. (repackager) |
| 35356-0068 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
More resources
Reyataz is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
